Literature DB >> 19403775

Rapid molecular characterization of Clostridium difficile and assessment of populations of C. difficile in stool specimens.

Danielle Wroblewski1, George E Hannett, Dianna J Bopp, Ghinwa K Dumyati, Tanya A Halse, Nellie B Dumas, Kimberlee A Musser.   

Abstract

Our laboratory has developed testing methods that use real-time PCR and pyrosequencing analysis to enable the rapid identification of potential hypervirulent Clostridium difficile strains. We describe a real-time PCR assay that detects four C. difficile genes encoding toxins A (tcdA) and B (tcdB) and the binary toxin genes (cdtA and cdtB), as well as a pyrosequencing assay that detects common deletions in the tcdC gene in less than 4 h. A subset of historical and recent C. difficile isolates (n = 31) was also analyzed by pulsed-field gel electrophoresis to determine the circulating North American pulsed-field (NAP) types that have been isolated in New York State. Thirteen different NAP types were found among the 31 isolates tested, 13 of which were NAP type 1 strains. To further assess the best approach to utilizing our conventional and molecular methods, we studied the populations of C. difficile in patient stool specimens (n = 23). Our results indicated that 13% of individual stool specimens had heterogeneous populations of C. difficile when we compared the molecular characterization results for multiple bacterial isolates (n = 10). Direct molecular analysis of stool specimens gave results that correlated well with the results obtained with cultured stool specimens; the direct molecular analysis was rapid, informative, and less costly than the testing of multiple patient stool isolates.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19403775      PMCID: PMC2708487          DOI: 10.1128/JCM.02498-08

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  32 in total

1.  Community-acquired Clostridium difficile diarrhea caused by binary toxin, toxin A, and toxin B gene-positive isolates in Hungary.

Authors:  Gabriella Terhes; Edit Urbán; József Sóki; Kanjo Abdul Hamid; Elisabeth Nagy
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

2.  Molecular analysis of Clostridium difficile PCR ribotype 027 isolates from Eastern and Western Canada.

Authors:  Duncan R MacCannell; Thomas J Louie; Dan B Gregson; Michel Laverdiere; Annie-Claude Labbe; Felicia Laing; Scott Henwick
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

3.  Comparative phylogenomics of Clostridium difficile reveals clade specificity and microevolution of hypervirulent strains.

Authors:  R A Stabler; D N Gerding; J G Songer; D Drudy; J S Brazier; H T Trinh; A A Witney; J Hinds; B W Wren
Journal:  J Bacteriol       Date:  2006-10       Impact factor: 3.490

4.  Binary toxin producing Clostridium difficile strains.

Authors:  M Rupnik; M Grabnar; B Geric
Journal:  Anaerobe       Date:  2003-12       Impact factor: 3.331

Review 5.  Emergence of Clostridium difficile-associated disease in North America and Europe.

Authors:  E J Kuijper; B Coignard; P Tüll
Journal:  Clin Microbiol Infect       Date:  2006-10       Impact factor: 8.067

6.  Clinical features of Clostridium difficile-associated diarrhoea due to binary toxin (actin-specific ADP-ribosyltransferase)-producing strains.

Authors:  Frédéric Barbut; Dominique Decré; Valérie Lalande; Béatrice Burghoffer; Latifa Noussair; Anne Gigandon; Florence Espinasse; Laurent Raskine; Jérome Robert; Alain Mangeol; Catherine Branger; Jean-Claude Petit
Journal:  J Med Microbiol       Date:  2005-02       Impact factor: 2.472

7.  Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates.

Authors:  Patrizia Spigaglia; Paola Mastrantonio
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

8.  Specific detection of toxigenic strains of Clostridium difficile in stool specimens.

Authors:  P H Gumerlock; Y J Tang; J B Weiss; J Silva
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

9.  Comparison of real-time PCR for detection of the tcdC gene with four toxin immunoassays and culture in diagnosis of Clostridium difficile infection.

Authors:  Lynne M Sloan; Brian J Duresko; Daniel R Gustafson; Jon E Rosenblatt
Journal:  J Clin Microbiol       Date:  2008-04-23       Impact factor: 5.948

10.  Clostridium difficile ribotype 027, toxinotype III, the Netherlands.

Authors:  Ed J Kuijper; Renate J van den Berg; Sylvia Debast; Caroline E Visser; Dick Veenendaal; Annet Troelstra; Tjallie van der Kooi; Susan van den Hof; Daan W Notermans
Journal:  Emerg Infect Dis       Date:  2006-05       Impact factor: 6.883

View more
  21 in total

1.  Clostridium difficile mixed infection and reinfection.

Authors:  David W Eyre; A Sarah Walker; David Griffiths; Mark H Wilcox; David H Wyllie; Kate E Dingle; Derrick W Crook; Tim E A Peto
Journal:  J Clin Microbiol       Date:  2011-11-09       Impact factor: 5.948

2.  Presence of multiple Clostridium difficile strains at primary infection is associated with development of recurrent disease.

Authors:  Anna M Seekatz; Emily Wolfrum; Christopher M DeWald; Rosemary K B Putler; Kimberly C Vendrov; Krishna Rao; Vincent B Young
Journal:  Anaerobe       Date:  2018-05-31       Impact factor: 3.331

3.  Intestinal inflammatory biomarkers and outcome in pediatric Clostridium difficile infections.

Authors:  Rana E El Feghaly; Jennifer L Stauber; Phillip I Tarr; David B Haslam
Journal:  J Pediatr       Date:  2013-09-04       Impact factor: 4.406

4.  Viral co-infections are common and are associated with higher bacterial burden in children with clostridium difficile infection.

Authors:  Rana E El Feghaly; Jennifer L Stauber; Phillip I Tarr; David B Haslam
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-12       Impact factor: 2.839

5.  Clostridium difficile ribotype does not predict severe infection.

Authors:  Seth T Walk; Dejan Micic; Ruchika Jain; Eugene S Lo; Itishree Trivedi; Eugene W Liu; Luay M Almassalha; Sarah A Ewing; Cathrin Ring; Andrzej T Galecki; Mary A M Rogers; Laraine Washer; Duane W Newton; Preeti N Malani; Vincent B Young; David M Aronoff
Journal:  Clin Infect Dis       Date:  2012-09-12       Impact factor: 9.079

6.  Clinical and laboratory characteristics of Clostridium difficile infection in patients with discordant diagnostic test results.

Authors:  Anna Kaltsas; Matt Simon; Larissa H Unruh; Crystal Son; Danielle Wroblewski; Kimberlee A Musser; Kent Sepkowitz; N Esther Babady; Mini Kamboj
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

7.  Premarket evaluations of the IMDx C. difficile for Abbott m2000 Assay and the BD Max Cdiff Assay.

Authors:  K A Stellrecht; A A Espino; V P Maceira; S M Nattanmai; S A Butt; D Wroblewski; G E Hannett; K A Musser
Journal:  J Clin Microbiol       Date:  2014-02-19       Impact factor: 5.948

8.  Markers of intestinal inflammation, not bacterial burden, correlate with clinical outcomes in Clostridium difficile infection.

Authors:  Rana E El Feghaly; Jennifer L Stauber; Elena Deych; Carlos Gonzalez; Phillip I Tarr; David B Haslam
Journal:  Clin Infect Dis       Date:  2013-03-13       Impact factor: 9.079

9.  Detection of mixed populations of Clostridium difficile from symptomatic patients using capillary-based polymerase chain reaction ribotyping.

Authors:  Adam A Behroozian; Jeffrey P Chludzinski; Eugene S Lo; Sarah A Ewing; Sheila Waslawski; Duane W Newton; Vincent B Young; David M Aronoff; Seth T Walk
Journal:  Infect Control Hosp Epidemiol       Date:  2013-07-12       Impact factor: 3.254

10.  Multilocus sequence typing of Clostridium difficile.

Authors:  David Griffiths; Warren Fawley; Melina Kachrimanidou; Rory Bowden; Derrick W Crook; Rowena Fung; Tanya Golubchik; Rosalind M Harding; Katie J M Jeffery; Keith A Jolley; Richard Kirton; Tim E Peto; Gareth Rees; Nicole Stoesser; Alison Vaughan; A Sarah Walker; Bernadette C Young; Mark Wilcox; Kate E Dingle
Journal:  J Clin Microbiol       Date:  2009-12-30       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.